585 related articles for article (PubMed ID: 19608019)
1. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
Ashour E; Samy N; Sayed M; Imam A
Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
5. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
6. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
7. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
10. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.
Romero-Gómez M; Castellano-Megias VM; Grande L; Irles JA; Cruz M; Nogales MC; Alcón JC; Robles A
Am J Gastroenterol; 2003 May; 98(5):1135-41. PubMed ID: 12809839
[TBL] [Abstract][Full Text] [Related]
12. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
13. The role of serum leptin levels in chronic hepatitis C with steatosis.
Ellidokuz E; Cömlekçi A; Ellidokuz H; Akpinar H; Gökçe C; Tankurt E; Sagol O; Simsek I; Gönen O
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxix-cclxxii. PubMed ID: 15244198
[TBL] [Abstract][Full Text] [Related]
14. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
16. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection.
Corbetta S; Redaelli A; Pozzi M; Bovo G; Ratti L; Redaelli E; Pellegrini C; Beck-Peccoz P; Spada A
Eur J Clin Invest; 2011 Aug; 41(8):898-905. PubMed ID: 21539538
[TBL] [Abstract][Full Text] [Related]
18. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function.
Risch L; Saely C; Hoefle G; Rein P; Langer P; Gouya G; Marte T; Aczel S; Drexel H
Clin Chim Acta; 2007 Feb; 376(1-2):108-13. PubMed ID: 16956602
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
[TBL] [Abstract][Full Text] [Related]
20. Increased serum resistin concentration in patients with chronic pancreatitis: possible cause of pancreatic fibrosis.
Adrych K; Smoczynski M; Sledzinski T; Dettlaff-Pokora A; Goyke E; Swierczynski J
J Clin Gastroenterol; 2009 Jan; 43(1):63-8. PubMed ID: 18827713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]